Immuron (IMRN) Interest & Investment Income (2017 - 2024)

Immuron's (IMRN) quarterly Interest & Investment Income came in at $35.3 billion in Q4 2024, up 23001335.32% year-on-year from N/an in Q1 2024, and up 23001335.32% quarter-over-quarter from $153508.0 in Q4 2023.

Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends

Immuron's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $35.3 billion for Q4 2024.

  • On a quarterly basis, Interest & Investment Income rose 23001335.32% year-over-year to $35.3 billion in Q4 2024; TTM through Dec 2024 was $35.3 billion, a 16998463.83% increase from a year earlier, with the FY2025 full-year figure at $88058.7, down 59.03% from the prior year.
  • Interest & Investment Income grew to $35.3 billion in Q4 2024 per IMRN's latest filing, from $153508.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $35.3 billion in Q4 2024 and bottomed at $63.29 in Q4 2020.
  • The 5-year median for Interest & Investment Income is $54072.0 (2022), against an average of $7.1 billion.
  • Across the five-year window, Interest & Investment Income gained 19.66% in 2021 and jumped 23001335.32% in 2024, its largest moves.
  • Year by year, Interest & Investment Income stood at $63.29 in 2020, then gained by 19.66% to $75.73 in 2021, then jumped by 71296.7% to $54072.0 in 2022, then soared by 183.9% to $153508.0 in 2023, then soared by 23001335.32% to $35.3 billion in 2024.
  • Per Business Quant, the three latest IMRN Interest & Investment Income figures stand at $35.3 billion (Q4 2024), $153508.0 (Q4 2023), and $54072.0 (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Immuron 255.19 Mn 243.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 35.31 Bn
Dec 31, 2023 153,508.00
Dec 31, 2022 54,072.00
Dec 31, 2021 75.73
Dec 31, 2020 63.29
Dec 31, 2019 2.59
Dec 31, 2018 39.00
Dec 31, 2017 33.51